EP 4 - Kiran Mazumdar-Shaw says Biocon’s ALZUMAb drug will put India on the global map
Lessons from Leaders by YourStory
Leadership Talks | Kiran Mazumdar-Shaw says Biocon’s ALZUMAb drug will put India on the global map. Biocon Founder Kiran Mazumdar-Shaw urges innovators to make more Made in India COVID-19 drugs and says she is proud of the biotech firm's ALZUMAb drug, which is helping save the lives of coronavirus patients. Read more at: https://yourstory.com/video/leadership-talks-kiran-mazumdar-shaw Follow us on Social Media: Facebook: www.facebook.com/yourstorycom Instagram: www.instagram.com/yourstory_com Twitter: www.twitter.com/YourStoryCo YouTube: www.youtube.com/yourstorytv Write to us: email@example.com This interview was originally hosted by Shradha Sharma on July 20, 2020. Presented by Julius Sharma!
Ep. 93: Compassionate Capitalism, with Biocon’s Kiran Mazumdar-Shaw
Conversations with Mike Milken
“I'm very committed to compassionate capitalism, which is what I like to call my business. … My products are there to help patients who need it anywhere in the world. And therefore, I believe that if I can actually produce these products in a way that provides affordable access … I will be very driven by that sense of purpose.”As one of India’s most celebrated biopharmaceutical entrepreneurs, Kiran Mazumdar-Shaw has been committed to healing the sick since she was 25. In 2010, Time magazine named her one the 100 most influential people in the world. Today, the executive chairperson of Biocon is determined to make a difference through both her philanthropy and her company’s promising COVID-19 treatment. Sadly, she may become a test patient herself: Shortly after this interview was recorded, she tested positive for the virus.“We did a proof of concept study in India with our drug and we actually got some very compelling results,” she tells Mike. “All the patients who took our drug recovered very well and in the small control arm, which did not take our drug, we had quite a few deaths. We got an emergency use approval from the regulator in India. We just received it a couple of weeks ago, and in these two weeks we've actually treated over a thousand patients in India, and most of them have recovered.”
KGI: Innovation in Applied Life Sciences & Healthcare
As part of the Pandemic Solutions: Virtual Speaker Series this summer, KGI President Sheldon Schuster interviews Kiran Mazumdar-Shaw in this episode. Mazumdar-Shaw is the Executive Chairperson and Managing Director of Biocon Limited, a globally recognized biopharmaceuticals company in India and the country’s leading biotech enterprise. Ms. Mazumdar-Shaw is a pioneer of the biotech industry in India and is recognized as a global thought leader. She is ranked among the “World’s 25 Most Influential People in Biopharma” by Fierce Biotech, Forbes Magazine’s “World’s 100 Most Powerful Women,” Fortune’s “Top 25 Most Powerful Women in Asia-Pacific,” and TIME Magazine’s “100 Most Influential People” in the world.
KIRAN MAZUMDAR-SHAW ON COVID, HEALTHCARE AND THE LIFE SCIENCES Kiran Mazumdar Shaw in conversation with Samanth Subramaniam
JLF Brave New World
Executive Chairperson, Biocon Limited, Kiran Mazumdar-Shaw, in conversation with writer and journalist, Samanth Subramanian, discusses the challenges of the Covid-19 pandemic and India’s response to it. They look into the way forward, and the opportunities the crisis throws up for India to emerge as a global hub for the life sciences.See omnystudio.com/listener for privacy information.
Dr. Kiran Mazumdar-Shaw talks to Pavan Srinath on day 1 of the 21 day lock down in India. She talks about the need for the lock down, the need for more focussed testing, the availability of test kits, vaccine development, treatment drugs and the opportunity for the Indian biotech sector to rise to the challenges.
Ep 45: Kiran Mazumdar-Shaw on handling criticism and trolls
With over a million Twitter followers and hundreds of thousands on other social platforms, Kiran Mazumdar Shaw keeps a really visible and busy profile. This fan following also brings trolls and critics who can get really personal at times. As I sat down with Shaw, the founder of India’s biggest biotech company, Biocon, to record the last Outliers podcast of 2017, I asked her how she manages criticism and trolls. “From the very start I’ve faced criticism…..being a woman entrepreneur, and trying to build a startup in an area not understood by many,” she told me. “More recently, some retail investors even asked me to step aside and hand over the reins to someone else who understands the business better. There’s even been criticism about my gender, and so on.” “I believe if you’re honest about your beliefs then you’ll be able to take criticism. I don’t hesitate in apologising or retracting what I said if someone points to factual inaccuracies etc..” In this age of extreme and polarized opinions, it doesn’t matter if you have one follower or a million. Keeping a balanced view and asking for fact/evidence-based debates on Twitter and elsewhere is scoffed upon. How does Shaw manage all that? How can she critique and praise the government at different times?These are among the questions I asked. Do listen in for some bold insights from one of the most important business leaders in the country.
India's "Mother of Invention", Kiran Mazumdar-Shaw, discusses the founding and growth of Biocon Ltd., Asia's largest biotech firm
University of Chicago Booth School of Business Podcast Series
Kiran Mazumdar-Shaw, founder and co-chair of Biocon, Ltd., Asia's largest biotech firm, started her journey by learning to brew beer. She became a master brewer in Australia and went home to India, where the brewing community promptly rejected her. On the rebound, she came across an Irish biotech entrepreneur who asked her if she'd like to start a biotech company in India.